SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?


To: Steve Stuart who wrote (8412)3/6/1998 2:03:00 PM
From: Scott H. Davis  Respond to of 14328
 
A POC article that did not make it to quote.yahoo.com. Link follows:

newsalert.com



To: Steve Stuart who wrote (8412)3/6/1998 2:32:00 PM
From: Keiko  Respond to of 14328
 
Steve,

I seem to remember a figure of $ 5 million and change for the Diagnostic segment of CNTO.

Shortly thereafter they purchased the Cancer market business from Centocor for an additional $ 1 million and change.

I will check my notes on those two purchases.

CDC is now in a real quandary and all their recent studies on HIV transmission has been set back several years with the recent news out of the White House Oval office. They have never heard any reports of getting sex from aids in recent history.



To: Steve Stuart who wrote (8412)3/6/1998 2:35:00 PM
From: AgAuUSA  Read Replies (1) | Respond to of 14328
 
S,

<Could this be it?>>

Believe Cnto Diag cost @ $5 million. Cancer markers cost $1.5 million.



To: Steve Stuart who wrote (8412)3/6/1998 3:26:00 PM
From: Bill Ounce  Respond to of 14328
 
to all:

Hey this earnings discussion is great. People arguing, but being polite about it. Next to no hype. Keep up the good work!

Now I see why people like to do "technical" trading. Don't have to pay attention to all these details!